Literature DB >> 21052735

Ectopic ACTH syndrome revealed as severe hypokalemia and persistent hypertension during the perioperative period: a case report.

Shun Kishimoto1, Kiichi Hirota, Hajime Segawa, Kazuhiko Fukuda.   

Abstract

Both severe hypokalemia and persistent hypertension are clinical symptoms of hyperaldosteronism. Hyperaldosteronism may occur as a primary or secondary syndrome. Excess ACTH produced ectopically by tumors may induce hyperaldosteronism through the mineralocorticoid activity of glucocorticoids that are upregulated by ACTH. Licorice, with the active ingredient glycyrrhiza, is also a well-known inducer of hyperaldosteronism under specific conditions. In this report, we describe a case of severe hypokalemia caused by ectopic ACTH syndrome (EAS) elicited by an intrathoracic carcinoid tumor, which had transformed to produce ACTH during the 6-year clinical course, and was modulated by licorice ingestion. Hypokalemia was not clearly recognized preoperatively but became obvious within 3 h of general anesthesia with epidural blockade. At the end of anesthesia, arterial blood gas analysis indicated severe hypokalemia ([K(+)] = 1.7 mEq/l) and metabolic alkalosis (pH 7.56, PaCO(2) = 54.9 mmHg, HCO(3)(-) = 44.5 mmol/l, BE = 21.8 mmol/l), without any typical symptoms such as muscle weakness or ECG abnormalities. The hypokalemia was resistant to potassium supplementation and persisted for 4 days. Perioperative imbalance between the administration and elimination of potassium and surgical stress might contribute to the rapid exacerbation and induce the clinical manifestation of EAS.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 21052735     DOI: 10.1007/s00540-010-1041-z

Source DB:  PubMed          Journal:  J Anesth        ISSN: 0913-8668            Impact factor:   2.078


  12 in total

1.  Liquorice-induced rise in blood pressure: a linear dose-response relationship.

Authors:  L Franzson; K Manhem; J Ragnarsson; G Sigurdsson; S Wallerstedt
Journal:  J Hum Hypertens       Date:  2001-08       Impact factor: 3.012

Review 2.  Association of hypertension and hypokalemia with Cushing's syndrome caused by ectopic ACTH secretion: a series of 58 cases.

Authors:  David J Torpy; Nancy Mullen; Ioannis Ilias; Lynnette K Nieman
Journal:  Ann N Y Acad Sci       Date:  2002-09       Impact factor: 5.691

3.  The ectopic adrenocorticotropin syndrome: clinical features, diagnosis, management, and long-term follow-up.

Authors:  Andrea M Isidori; Gregory A Kaltsas; Carlotta Pozza; Vanni Frajese; John Newell-Price; Rodney H Reznek; Paul J Jenkins; John P Monson; Ashley B Grossman; G Michael Besser
Journal:  J Clin Endocrinol Metab       Date:  2005-11-22       Impact factor: 5.958

4.  Ectopic ACTH syndrome: our experience with 25 cases.

Authors:  Luiz Roberto Salgado; Maria Candida B Villares Fragoso; Mirta Knoepfelmacher; Marcio Carlos Machado; Sorahia Domenice; Maria Adelaide Albergaria Pereira; Berenice Bilharinho de Mendonça
Journal:  Eur J Endocrinol       Date:  2006-11       Impact factor: 6.664

5.  Prospective study of thymic carcinoids in patients with multiple endocrine neoplasia type 1.

Authors:  Fathia Gibril; Yuan-Jia Chen; David S Schrump; Alexander Vortmeyer; Zhengping Zhuang; Irina A Lubensky; James C Reynolds; Adeline Louie; Laurence K Entsuah; Kane Huang; Behnam Asgharian; Robert T Jensen
Journal:  J Clin Endocrinol Metab       Date:  2003-03       Impact factor: 5.958

6.  Mediastinal endocrine neoplasm, of probable thymic origin, related to carcinoid tumor. Clinicopathologic study of 8 cases.

Authors:  J Rosai; E Higa
Journal:  Cancer       Date:  1972-04       Impact factor: 6.860

7.  The ectopic ACTH syndrome.

Authors:  G W Liddle; J R Givens; W E Nicholson; D P Island
Journal:  Cancer Res       Date:  1965-08       Impact factor: 12.701

Review 8.  Mineralocorticoid hypertension.

Authors:  P M Stewart
Journal:  Lancet       Date:  1999-04-17       Impact factor: 79.321

Review 9.  11 beta-Hydroxysteroid dehydrogenase: new answers, new questions.

Authors:  J W Funder
Journal:  Eur J Endocrinol       Date:  1996-03       Impact factor: 6.664

10.  Mineralocorticoid hypertension.

Authors:  R D Gordon
Journal:  Lancet       Date:  1994-07-23       Impact factor: 79.321

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.